Angiotensin‐converting enzyme inhibitors vs ARB
Cardiovascular events · people with primary hypertension
All angiotensin converting enzyme (ACE) inhibitors showed no clear difference in total cardiovascular events compared with all angiotensin receptor blockers (ARBs) (low certainty).
1 finding from 1 review
- Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension 2014 · Cochrane Headline outcomes onlyRR 1.07 [0.96, 1.19]3 studies · 5499 participantsLow